Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

SMS PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 14.8414.4512.358.4110.14

What is the latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS is 14.84 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202514.84
Mar202414.45
Mar202312.35
Mar20228.41
Mar202110.14

How is EV/Core EBITDA of SMS PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 14.84
2.70
Mar2024 14.45
17.00
Mar2023 12.35
46.85
Mar2022 8.41
-17.06
Mar2021 10.14 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹3,974.3 Cr 2.1% 5.3% 110.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

2.1%

5.3%

110.8%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses